On the other hand, the clinical value of radiolabeled GLP-1R-antagonists based on Ex(9-39) remains controversial as well, with most researchers disputing the applicability of related radioligands in insulinoma imaging, let alone treatment. Here, GLP1R is linked to pancreatic insulinoma.